Financials Getinge AB

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 11:19:25 16/07/2024 BST 5-day change 1st Jan Change
184 SEK -0.92% Intraday chart for Getinge AB +1.43% -17.81%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 47,392 52,322 107,613 58,914 61,092 50,579 - -
Enterprise Value (EV) 1 56,158 56,472 111,222 61,516 69,104 56,912 55,005 52,813
P/E ratio 38.8 x 16.2 x 36.2 x 23.6 x 25.3 x 19.3 x 16.3 x 14.5 x
Yield 0.86% 1.56% 1.01% 1.96% 1.96% 2.46% 2.76% 3.09%
Capitalization / Revenue 1.78 x 1.75 x 3.98 x 2.08 x 1.92 x 1.49 x 1.43 x 1.37 x
EV / Revenue 2.11 x 1.89 x 4.11 x 2.17 x 2.17 x 1.68 x 1.56 x 1.43 x
EV / EBITDA 11.3 x 7.54 x 16.5 x 10.4 x 12.4 x 9.1 x 7.94 x 7.02 x
EV / FCF 21.5 x 9.18 x 19.8 x 32.4 x 43.1 x 16.4 x 16 x 13.6 x
FCF Yield 4.65% 10.9% 5.06% 3.08% 2.32% 6.08% 6.24% 7.36%
Price to Book 2.26 x 2.44 x 4.27 x 1.93 x 2.01 x 1.57 x 1.48 x 1.4 x
Nbr of stocks (in thousands) 272,370 272,370 272,370 272,370 272,370 272,370 - -
Reference price 2 174.0 192.1 395.1 216.3 224.3 185.7 185.7 185.7
Announcement Date 30/01/20 28/01/21 28/01/22 01/02/23 01/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 26,559 29,819 27,049 28,292 31,827 33,875 35,366 36,956
EBITDA 1 4,986 7,487 6,754 5,891 5,574 6,256 6,924 7,518
EBIT 1 2,813 5,261 4,939 4,096 3,653 4,196 4,753 5,282
Operating Margin 10.59% 17.64% 18.26% 14.48% 11.48% 12.39% 13.44% 14.29%
Earnings before Tax (EBT) 1 1,909 4,485 4,188 3,472 3,343 3,660 4,338 4,868
Net income 1 1,222 3,239 2,970 2,491 2,412 2,654 3,113 3,529
Net margin 4.6% 10.86% 10.98% 8.8% 7.58% 7.84% 8.8% 9.55%
EPS 2 4.480 11.89 10.90 9.150 8.860 9.622 11.38 12.77
Free Cash Flow 1 2,612 6,154 5,630 1,897 1,604 3,462 3,433 3,888
FCF margin 9.83% 20.64% 20.81% 6.71% 5.04% 10.22% 9.71% 10.52%
FCF Conversion (EBITDA) 52.39% 82.2% 83.36% 32.2% 28.78% 55.34% 49.58% 51.72%
FCF Conversion (Net income) 213.75% 190% 189.56% 76.15% 66.5% 130.41% 110.3% 110.2%
Dividend per Share 2 1.500 3.000 4.000 4.250 4.400 4.576 5.122 5.730
Announcement Date 30/01/20 28/01/21 28/01/22 01/02/23 01/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 7,987 6,182 6,670 6,941 8,498 7,141 7,176 7,607 9,903 7,513 7,943 8,175 10,259 7,778 8,020
EBITDA 1 2,118 1,235 1,350 1,579 1,727 1,380 902 1,525 1,766 1,255 1,231 1,568 2,115 1,398 1,426
EBIT 1 1,652 797 913 1,121 1,265 921 442 1,047 1,243 784 794.4 1,084 1,648 - -
Operating Margin 20.68% 12.89% 13.69% 16.15% 14.89% 12.9% 6.16% 13.76% 12.55% 10.44% 10% 13.26% 16.06% - -
Earnings before Tax (EBT) 1 1,075 749 867 1,075 781 826 305 1,227 986 638 587.7 880.9 1,408 778 806
Net income 1 771 534 603 798 556 586 214 894 718 459 420.3 629.8 1,007 547 567
Net margin 9.65% 8.64% 9.04% 11.5% 6.54% 8.21% 2.98% 11.75% 7.25% 6.11% 5.29% 7.7% 9.82% 7.03% 7.07%
EPS 2 2.830 1.960 2.210 2.930 2.040 2.150 0.7900 3.280 2.640 1.690 1.549 2.312 3.697 2.010 2.080
Dividend per Share 4.000 - - - - - - - - - - - - - -
Announcement Date 28/01/22 26/04/22 19/07/22 19/10/22 01/02/23 26/04/23 18/07/23 23/10/23 01/02/24 22/04/24 - - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 8,766 4,150 3,609 2,602 8,012 6,333 4,426 2,234
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.758 x 0.5543 x 0.5344 x 0.4417 x 1.437 x 1.012 x 0.6392 x 0.2972 x
Free Cash Flow 1 2,612 6,154 5,630 1,897 1,604 3,462 3,433 3,888
ROE (net income / shareholders' equity) 6.2% 15.1% 12.9% 8.9% 7.8% 8.45% 9.22% 9.87%
ROA (Net income/ Total Assets) 2.77% 7.22% 6.63% 5.16% 4.74% 4.8% 5.5% 5.97%
Assets 1 44,116 44,863 44,785 48,294 50,889 55,301 56,595 59,137
Book Value Per Share 2 77.00 78.90 92.40 112.0 112.0 118.0 125.0 133.0
Cash Flow per Share 2 14.10 26.40 24.10 - 10.90 21.20 17.40 18.80
Capex 1 1,220 1,045 930 1,136 1,353 1,423 1,492 1,550
Capex / Sales 4.59% 3.5% 3.44% 4.02% 4.25% 4.2% 4.22% 4.2%
Announcement Date 30/01/20 28/01/21 28/01/22 01/02/23 01/02/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
185.7 SEK
Average target price
224.9 SEK
Spread / Average Target
+21.10%
Consensus